NCT06103630 Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device
| NCT ID | NCT06103630 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cheng-Kung University Hospital |
| Condition | Obstructive Sleep Apnea of Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-11-02 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-11-02 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Oropharyngeal muscle training has emerged as a novel adjunctive treatment approach, involving training of the swallowing muscle group and tongue muscles to prevent tongue collapse, reduce tongue base volume during sleep, and strengthen muscle tension. Therefore, the objective is to assess changes in oropharyngeal muscle strength, ultrasonographic tongue morphology, severity of sleep related breathing interruptions, clinical symptoms, and correlations among these factors. Oropharyngeal muscle training for patients with residual OSA using MAD can significantly 1. increase muscle strength and endurance. 2. reduce the severity of sleep-related breathing interruptions. 3. decrease clinical symptoms. 4. improve tongue morphology.
Eligibility Criteria
Inclusion Criteria: * OSA patients * Aged over 20 years * Wearing MAD (The amount of MAD is at least 50% of the maximum amount that the patient can achieve.) Exclusion Criteria: * Body Mass Index (BMI) ≧ 35 * Pregnancy * Severe obstructive or restrictive lung disease * Exercise with high-risk cardiovascular disease * History of central or peripheral neurological disease resulting in an inability to perform exercise prescriptions * Musculoskeletal or psychological disorders that prevent the performance of exercise prescriptions * Chronic illnesses that are ongoing or not yet controlled
Contact & Investigator
Ching-Hsia Hung, PhD
PRINCIPAL INVESTIGATOR
National Cheng Kung University
Frequently Asked Questions
Who can join the NCT06103630 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Obstructive Sleep Apnea of Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06103630 currently recruiting?
Yes, NCT06103630 is actively recruiting participants. Contact the research team at amymanhui@gmail.com for enrollment information.
Where is the NCT06103630 trial being conducted?
This trial is being conducted at Tainan, Taiwan.
Who is sponsoring the NCT06103630 clinical trial?
NCT06103630 is sponsored by National Cheng-Kung University Hospital. The principal investigator is Ching-Hsia Hung, PhD at National Cheng Kung University. The trial plans to enroll 20 participants.